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ples suggest that by first treating a sam-
ple with PMA and covalently modifying
the DNA originating from dead cells,
downstream FISH-based mi croscopy
should then enable the direct, specific
visualization and enumeration of only
living, viable microorganisms. An effec-
tive and efficient coupling of PMA-
based chemistry with downstream
FISH-microscopic methods would sig-
nificantly empower the current ability
to discern viable from dead microbes
by direct visualization.
The basic principle of this method is
that PMA penetrates only the dead cells
and/or spores, due to their compro-
mised membrane structures. Once in-
side the cell, PMA strongly intercalates
with DNA. PMA has a photoactive azide
group that allows covalent cross-linkage
to DNA upon exposure to bright white
light. This photoactivation results in the
formation of PMA-DNA complex that
renders DNA inaccessible for hybridiza-
tion reaction during FISH assay. To
avoid the difficulties and problems asso-
ciated with current methods for deter-
mining the actual numbers of living ver-
sus dead cellular entities examined, and
biases associated therewith, a novel mo-
lecular-biological protocol was devel-
oped for selective detection and enu-
meration of viable microbial cells. After
having been subjected to the procedures
described herein, the viability (live vs.
dead) of bacterial cells and spores could
be discerned. Following treatment with
PMA, living, viable cells and spores were
shown to be receptive to fluorescently la-
beled oligonucleotide probes, as hy-
bridization and FISH-based mi cros copy
was successful. Dead cells and spores,
however, were not detected, as the pre-
treatment with PMA rendered their
DNA unavailable to hybridization with
the FISH-probes.
The true novelty of the technology is
the coupling of a downstream, highly
specific means of visualizing microbial
cells and spores with a chemical pre-
treatment that precludes the portion of
the microbial consortium that is not 
living (non-viable) from being detected.
This results in the ability to selectively 
visualize and enumerate only the living
cells and spores present in a given sam-
ple, in a molecular biological fashion,
without the need for heavily biased culti-
vation-based methodologies. This novel
study demonstrates that PMA penetrates
only the heat-killed spores, which pre-
cludes downstream hybridization reac-
tions in the FISH assay. This novel PMA-
FISH method is an attractive tool to
detect viable endospores in space craft-
associated environments, which is of
crucial importance and benefit to plane-
tary protection practices aimed at reduc-
ing the abundance of spacecraft-borne
microbial contaminants.
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There are several medical conditions
that require intravenous (IV) fluids.
Limitations of mass, volume, storage
space, shelf-life, transportation, and
local resources can restrict the availabil-
ity of such important fluids. These limi-
tations are expected in long-duration
space exploration missions and in re-
mote or austere environments on Earth.
Current IV fluid production requires
large factory-based processes. Easy,
portable, on-site production of IV fluids
can eliminate these limitations. Based
on experience gained in developing a
device for spaceflight, a ground-use de-
vice was developed.
This design uses regular drinking
water that is pumped through two filters
to produce, in minutes, sterile, ultra-
pure water that meets the stringent
quality standards of the United States
Pharmacopeia for Water for Injection
(Total Bacteria, Conductivity, Endo -
toxins, Total Organic Carbon). The de-
vice weighs 2.2 lb (1 kg) and is 10 in.
long, 5 in. wide, and 3 in. high (≈25, 13,
and 7.5 cm, respectively) in its storage
configuration. This handheld device
produces one liter of medical-grade
water in 21 minutes. Total production
capacity for this innovation is expected
to be in the hundreds of liters. 
The device contains one battery pow-
ered electric mini-pump. Alternatively,
a manually powered pump can be at-
tached and used. Drinking water enters
the device from a source water bag,
flows through two filters, and final ster-
ile production water exits into a sealed,
medical-grade collection bag. The col-
lection bag contains pre-placed crys-
talline salts to mix with product water
to form isotonic intravenous medical
solutions. Alternatively, a hypertonic
salt solution can be injected into a filled
bag. The filled collection bag is de-
tached from the device and is ready for
use or storage. This device currently
contains one collection bag, but a man-
ifold of several pre-attached bags or re-
placement of single collection bags
under sterile needle technique is possi-
ble for the production of multiple
liters. The entire system will be flushed,
sealed, and radiation-sterilized.
Operation of the device is easy and re-
quires minimal training. Drinking water
is placed into the collection bag. Inline
stopcock flow valves at the source and
collection bags are opened, and the
mini-pump is turned on by a switch to
begin fluid flow. When the collection
bag is completely filled with the med-
ical-grade water, the pump can be
turned off. The pump is designed so it
cannot pump air, and overfilling of the
collection bag with fluid is avoided by
placing an equal amount of water in the
source bag. Backflow is avoided by in-
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line check valves. The filled collection
bag is disconnected from its tubing and
is ready for use. The source bag can be
refilled for production of multiple
liters, or the source bag can be replaced
with an input tube that can be placed in
a larger potable water source if the de-
vice is attended. The device functions in
all orientations independent of any
gravity fields. 
In addition to creating IV fluids, the
device produces medical-grade water,
which can be used for mixing with med-
ications for injection, reconstituting
freeze-dried blood products for injection,
or for wound hydration or irrigation. 
Potential worldwide use is expected
with medical activities in environments
that have limited resources, storage, or
resupply such as in military field opera-
tions, humanitarian relief efforts, sub-
marines, commercial cruise ships, etc. 
This work was done by Philip J. Scarpa of
Kennedy Space Center and Wolfgang K.
Scheuer of Tiger Purification Systems, Inc. For
more information, contact Dr. Philip Scarpa at
(321) 867-6386 or Philip.J.Scarpa@nasa.gov.
KSC-13598
A report describes an adaptation of a
filter assembly to enable it to be used to
filter out microorganisms from a propul-
sion system. The filter assembly has pre-
viously been used for particulates >2 µm.
Projects that utilize large volumes of
nonmetallic materials of planetary pro-
tection concern pose a challenge to
their bioburden budget, as a conserva-
tive specification value of 30 spores/cm3
is typically used. 
Helium was collected utilizing an
adapted filtration approach employing
an existing Millipore filter assembly ap-
paratus used by the propulsion team for
particulate analysis. The filter holder on
the assembly has a 47-mm diameter, and
typically a 1.2-5 µm pore-size filter is
used for particulate analysis making it
compatible with commercially available
sterilization filters (0.22 µm) that are
necessary for biological sampling. 
This adaptation to an existing tech-
nology provides a proof-of-concept and
a demonstration of successful use in a
ground equipment system. This adapta-
tion has demonstrated that the Millipore
filter assembly can be utilized to filter
out microorganisms from a propulsion
system, whereas in previous uses the fil-
ter assembly was utilized for particulates
>2 µm. 
This work was done by James N. Benardini,
Robert C. Koukol, Wayne W. Schubert, Fabian
Morales, and Marlin F. Klatte of Caltech for
NASA’s Jet Propulsion Laboratory. Further in-
formation is contained in a TSP (see page 1).
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